IRTC share price soared by 35% after the company made the headlines thanks to the appointment of a new CEO.
In early April, IRTC stock price crashed following its inability to secure a profitable reimbursement rate for the Zio XT, its main product. Despite this, the company is poised to increase its revenues by 22% this year. Following the appointment of its new CEO, the company made the headlines and its share price popped.
If you want to find out more about IRTC and where you can buy (or short-sell) it right now, check out the following sections.
How & Where to Buy IRTC Stock Online
iRhythm Technologies (IRTC) is listed on the Nasdaq stock exchange. You can trade or invest in its shares by registering with an online broker that provides access to this asset. Our top choices are:
Pepperstone was founded in 2010 in Melbourne, Australia by a team of experienced traders with a shared commitment to improve the world of online trading. Frustrated by delayed executions, expensive prices and poor customer support, they set out to provide traders around the world with superior technology, low-cost spreads and a genuine commitment to helping them master the trade. Their mission is to create a world of tech-enabled trading where ambitious traders can embrace the challenge and opportunity of global markets.
Register with Pepperstone instantly
eToro is one of the world’s leading multi-asset trading platforms offering some of the lowest commission and fee rates in the industry. It’s social copy trading features make it a great choice for those getting started.
Register with eToro instantly
What Is IRTC?
iRhythm Technologies (IRTC) is the only manufacturer of simple solutions for detecting heart arrhythmias. Its main product is the Zio XT, a detection device for high-risk patients who can use it to detect this life-threatening condition.
Should I Buy IRTC Today?
The company has recently made the headlines as it appointed a new CEO, Quentin Blackford, the former chief operating officer of DexCom. Blackford managed to successfully lead DexCom, which is a profitable manufacturer of blood glucose monitors. This time, it seems that investors expect Blackford to turn IRTC profitable – just as DexCom’s operations were last year.
Given the track record of success of the newly appointed CEO who is to take the helm on the 4th of October, IRTC may be a great buy opportunity right now. Not to mention that it is the only manufacturer of devices that can detect life-threatening heart arrhythmias.
Despite this, many would be tempted to believe that the stock is due for a correction in today’s session as the 35% increase solely based on this news might seem like the market overreacted. So, this would make this stock a great short-selling opportunity instead.
IRTC Price Prediction 2021
Analysts have a high price prediction of $80. The minimum estimate is $55, with a median of $65, which is the current share price.
Credit: Source link